Article
Developing a Stepwise Induction Protocol for Cisplatin-Resistant Human Cervical Cancer Cells
2025-11-21
Abstract excerpt
Cisplatin, a platinum-based DNA crosslinking chemotherapeutic, remains the cornerstone of first-line chemoradiation therapy for advanced cervical cancer. However, the clinical efficacy of cisplatin is frequently compromised by the emergence of acquired resistance, which represents a principal cause of treatment failure and disease recurrence. Traditional protocols for generating resistant cervical cancer cell line...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3bf39da3-8ea0-5a39-835f-7cd8c066b350
- DOI
- 10.1101/2025.11.20.687683
